Inactive Instrument

Company Health Sciences Group, Inc. Other OTC

Equities

HESG

US42223A1007

Biotechnology & Medical Research

Business Summary

Health Sciences Group, Inc. identifies, develops and commercializes products and functional food ingredients derived from natural sources to provide consumers and healthcare professionals with preventive healthcare alternatives. The Company has two operating subsidiaries: BioSelect Innovations, Inc. and Swiss Research, Inc. BioSelect Innovations has developed a number of product formulations. These patents address the integration of selective traditional over-the-counter generic drugs with complementary alternative medications, such as vitamins, herbs and other natural nutraceutical supplements. Swiss Research is a diet and nutrition products company, which markets and sells Shugr, a zero-calorie and diabetic safe sugar substitute with the look, taste and baking qualities of cane sugar. The Company will launch its new product, Sequesterol Advance Cardio Formula in April 2006.

Sales per Business

USD in Million2012Weight Delta
Online Customer Communities
100.0 %
0 100.0 % -

Sales per region

USD in Million2012Weight Delta
United States
100.0 %
0 100.0 % -

Managers

Managers TitleAgeSince
President - 12/06/96

Members of the board

Members of the board TitleAgeSince
President - 12/06/96

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 3,066 0 0 100.00 %
Stock B 0 26 0 0
Stock C 1 18,709,356,099 18,709,356,099 ( 100.00 %) 0
Stock D 0 1,267,816 0 0

Company contact information

Health Sciences Group, Inc.

14331 Euclid Street Suite 207

92843, Garden Grove

+

address Health Sciences Group, Inc.(HESG)
  1. Stock Market
  2. Equities
  3. HESG Stock
  4. HESG Stock
  5. Company Health Sciences Group, Inc.